Clinical Features, Prognosis, and Prognostic Factors of Remnant Gastric Cancer Patients Who Received Potentially Curative Gastrectomy
In Vivo · 2026
DOI: 10.21873/invivo.14206 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Toru Aoyama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan t-aoyama@lilac.plala.or.jp. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Gastric Stump, Adenocarcinoma. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastric Surgery Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan t-aoyama@lilac.plala.or.jp.
- Department of Gastric Surgery Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Zitieren
APA
Aoyama, T., Cho, H., Suematsu, H., & Hara, K. (2026). Clinical Features, Prognosis, and Prognostic Factors of Remnant Gastric Cancer Patients Who Received Potentially Curative Gastrectomy. In Vivo. https://doi.org/10.21873/invivo.14206
Vancouver
Aoyama T, Cho H, Suematsu H, Hara K. Clinical Features, Prognosis, and Prognostic Factors of Remnant Gastric Cancer Patients Who Received Potentially Curative Gastrectomy. In Vivo. 2026. doi:10.21873/invivo.14206
BibTeX
@article{Aoyama2026,
author = {Aoyama, Toru and Cho, Haruhiko and Suematsu, Hideaki and Hara, Kentaro},
title = {Clinical Features, Prognosis, and Prognostic Factors of Remnant Gastric Cancer Patients Who Received Potentially Curative Gastrectomy},
journal = {In Vivo},
year = {2026},
doi = {10.21873/invivo.14206}
}
EUVIMED